-
1
-
-
0030756394
-
Natural polyreactive secretory immunoglobulin A autoantibodies as a possible barrier to infection in humans
-
Quan, C. P., A. Berneman, R. Pires, S. Avrameas, and J. P. Bouvet. 1997. Natural polyreactive secretory immunoglobulin A autoantibodies as a possible barrier to infection in humans. Infect. Immun. 65: 3997-4004.
-
(1997)
Infect. Immun.
, vol.65
, pp. 3997-4004
-
-
Quan, C.P.1
Berneman, A.2
Pires, R.3
Avrameas, S.4
Bouvet, J.P.5
-
2
-
-
0032533818
-
Secretory component delays the conversion of secretory IgA into antigen-binding competent F(ab9)2: A possible implication for mucosal defense
-
Crottet, P., and B. Corthésy. 1998. Secretory component delays the conversion of secretory IgA into antigen-binding competent F(ab9)2: a possible implication for mucosal defense. J. Immunol. 161: 5445-5453.
-
(1998)
J. Immunol.
, vol.161
, pp. 5445-5453
-
-
Crottet, P.1
Corthésy, B.2
-
3
-
-
84882860611
-
Biological activities of IgA
-
3rd ed. J. Mestecky, M. E. Lamm, W. Strober, J. Bienenstock, J. R. McGhee, and L. Mayer, eds. Elsevier Academic Press, Amsterdam, The Netherlands
-
Russell, M. W., and M. Kilian. 2005. Biological activities of IgA. In Mucosal Immunology, 3rd ed. J. Mestecky, M. E. Lamm, W. Strober, J. Bienenstock, J. R. McGhee, and L. Mayer, eds. Elsevier Academic Press, Amsterdam, The Netherlands, p. 267-289.
-
(2005)
Mucosal Immunology
, pp. 267-289
-
-
Russell, M.W.1
Kilian, M.2
-
4
-
-
0029863522
-
B-1 cells and their reactivity with the murine intestinal microflora
-
Kroese, F. G., R. de Waard, and N. A. Bos. 1996. B-1 cells and their reactivity with the murine intestinal microflora. Semin. Immunol. 8: 11-18.
-
(1996)
Semin. Immunol.
, vol.8
, pp. 11-18
-
-
Kroese, F.G.1
De Waard, R.2
Bos, N.A.3
-
5
-
-
0029155360
-
Commensal enteric bacteria engender a self-limiting humoral mucosal immune response while permanently colonizing the gut
-
Shroff, K. E., K. Meslin, and J. J. Cebra. 1995. Commensal enteric bacteria engender a self-limiting humoral mucosal immune response while permanently colonizing the gut. Infect. Immun. 63: 3904-3913.
-
(1995)
Infect. Immun.
, vol.63
, pp. 3904-3913
-
-
Shroff, K.E.1
Meslin, K.2
Cebra, J.J.3
-
6
-
-
0031940494
-
In vitro comparison of the biologic activities of monoclonal monomeric IgA, polymeric IgA, and secretory IgA
-
Renegar, K. B., G. D. Jackson, and J. Mestecky. 1998. In vitro comparison of the biologic activities of monoclonal monomeric IgA, polymeric IgA, and secretory IgA. J. Immunol. 160: 1219-1223.
-
(1998)
J. Immunol.
, vol.160
, pp. 1219-1223
-
-
Renegar, K.B.1
Jackson, G.D.2
Mestecky, J.3
-
7
-
-
0019256014
-
Epidemiologic studies of Streptococcus pneumoniae in infants: Acquisition, carriage, and infection during the first 24 months of life
-
Gray, B. M., G. M. Converse, 3rd, and H. C. Dillon, Jr. 1980. Epidemiologic studies of Streptococcus pneumoniae in infants: acquisition, carriage, and infection during the first 24 months of life. J. Infect. Dis. 142: 923-933.
-
(1980)
J. Infect. Dis.
, vol.142
, pp. 923-933
-
-
Gray, B.M.1
Converse III, G.M.2
Dillon Jr., H.C.3
-
8
-
-
0034063425
-
Efficacy, safety and immunogenicity of heptavalent pneumococcal conjugate vaccine in children
-
Northern California Kaiser Permanente Vaccine Study Center Group
-
Black, S., H. Shinefield, B. Fireman, E. Lewis, P. Ray, J. R. Hansen, L. Elvin, K. M. Ensor, J. Hackell, G. Siber, et al; Northern California Kaiser Permanente Vaccine Study Center Group. 2000. Efficacy, safety and immunogenicity of heptavalent pneumococcal conjugate vaccine in children. Pediatr. Infect. Dis. J. 19: 187-195.
-
(2000)
Pediatr. Infect. Dis. J.
, vol.19
, pp. 187-195
-
-
Black, S.1
Shinefield, H.2
Fireman, B.3
Lewis, E.4
Ray, P.5
Hansen, J.R.6
Elvin, L.7
Ensor, K.M.8
Hackell, J.9
Siber, G.10
-
9
-
-
0242684416
-
Decline in invasive pneumococcal disease after the introduction of protein-polysaccharide conjugate vaccine
-
Active Bacterial Core Surveillance of the Emerging Infections Program Network
-
Whitney, C. G., M. M. Farley, J. Hadler, L. H. Harrison, N. M. Bennett, R. Lynfield, A. Reingold, P. R. Cieslak, T. Pilishvili, D. Jackson, et al; Active Bacterial Core Surveillance of the Emerging Infections Program Network. 2003. Decline in invasive pneumococcal disease after the introduction of protein-polysaccharide conjugate vaccine. N. Engl. J. Med. 348: 1737-1746.
-
(2003)
N. Engl. J. Med.
, vol.348
, pp. 1737-1746
-
-
Whitney, C.G.1
Farley, M.M.2
Hadler, J.3
Harrison, L.H.4
Bennett, N.M.5
Lynfield, R.6
Reingold, A.7
Cieslak, P.R.8
Pilishvili, T.9
Jackson, D.10
-
10
-
-
58349094326
-
Effect of pneumococcal conjugate vaccine on pneumococcal meningitis
-
Hsu, H. E., K. A. Shutt, M. R. Moore, B. W. Beall, N. M. Bennett, A. S. Craig, M. M. Farley, J. H. Jorgensen, C. A. Lexau, S. Petit, et al. 2009. Effect of pneumococcal conjugate vaccine on pneumococcal meningitis. N. Engl. J. Med. 360: 244-256.
-
(2009)
N. Engl. J. Med.
, vol.360
, pp. 244-256
-
-
Hsu, H.E.1
Shutt, K.A.2
Moore, M.R.3
Beall, B.W.4
Bennett, N.M.5
Craig, A.S.6
Farley, M.M.7
Jorgensen, J.H.8
Lexau, C.A.9
Petit, S.10
-
11
-
-
34247498668
-
Invasive pneumococcal disease caused by nonvaccine serotypes among alaska native children with high levels of 7-valent pneumococcal conjugate vaccine coverage
-
Singleton, R. J., T. W. Hennessy, L. R. Bulkow, L. L. Hammitt, T. Zulz, D. A. Hurlburt, J. C. Butler, K. Rudolph, and A. Parkinson. 2007. Invasive pneumococcal disease caused by nonvaccine serotypes among alaska native children with high levels of 7-valent pneumococcal conjugate vaccine coverage. JAMA 297: 1784-1792.
-
(2007)
JAMA
, vol.297
, pp. 1784-1792
-
-
Singleton, R.J.1
Hennessy, T.W.2
Bulkow, L.R.3
Hammitt, L.L.4
Zulz, T.5
Hurlburt, D.A.6
Butler, J.C.7
Rudolph, K.8
Parkinson, A.9
-
12
-
-
0034773167
-
Intranasal vaccination with pneumococcal surface protein A and interleukin-12 augments antibody-mediated opsonization and protective immunity against Streptococcus pneumoniae infection
-
Arulanandam, B. P., J. M. Lynch, D. E. Briles, S. K. Hollingshead, and D. W. Metzger. 2001. Intranasal vaccination with pneumococcal surface protein A and interleukin-12 augments antibody-mediated opsonization and protective immunity against Streptococcus pneumoniae infection. Infect. Immun. 69: 6718-6724.
-
(2001)
Infect. Immun.
, vol.69
, pp. 6718-6724
-
-
Arulanandam, B.P.1
Lynch, J.M.2
Briles, D.E.3
Hollingshead, S.K.4
Metzger, D.W.5
-
13
-
-
0042665483
-
Immunizations with pneumococcal surface protein A and pneumolysin are protective against pneumonia in a murine model of pulmonary infection with Streptococcus pneumoniae
-
Briles, D. E., S. K. Hollingshead, J. C. Paton, E. W. Ades, L. Novak, F. W. van Ginkel, and W. H. Benjamin, Jr. 2003. Immunizations with pneumococcal surface protein A and pneumolysin are protective against pneumonia in a murine model of pulmonary infection with Streptococcus pneumoniae. J. Infect. Dis. 188: 339-348.
-
(2003)
J. Infect. Dis.
, vol.188
, pp. 339-348
-
-
Briles, D.E.1
Hollingshead, S.K.2
Paton, J.C.3
Ades, E.W.4
Novak, L.5
Van Ginkel, F.W.6
Benjamin Jr., W.H.7
-
14
-
-
33845980590
-
Development of a vaccine against invasive pneumococcal disease based on combinations of virulence proteins of Streptococcus pneumoniae
-
Ogunniyi, A. D., M. Grabowicz, D. E. Briles, J. Cook, and J. C. Paton. 2007. Development of a vaccine against invasive pneumococcal disease based on combinations of virulence proteins of Streptococcus pneumoniae. Infect. Immun. 75: 350-357.
-
(2007)
Infect. Immun.
, vol.75
, pp. 350-357
-
-
Ogunniyi, A.D.1
Grabowicz, M.2
Briles, D.E.3
Cook, J.4
Paton, J.C.5
-
15
-
-
0033680686
-
Immunization of humans with recombinant pneumococcal surface protein A (rPspA) elicits antibodies that passively protect mice from fatal infection with Streptococcus pneumoniae bearing heterologous PspA
-
Briles, D. E., S. K. Hollingshead, J. King, A. Swift, P. A. Braun, M. K. Park, L. M. Ferguson, M. H. Nahm, and G. S. Nabors. 2000. Immunization of humans with recombinant pneumococcal surface protein A (rPspA) elicits antibodies that passively protect mice from fatal infection with Streptococcus pneumoniae bearing heterologous PspA. J. Infect. Dis. 182: 1694-1701.
-
(2000)
J. Infect. Dis.
, vol.182
, pp. 1694-1701
-
-
Briles, D.E.1
Hollingshead, S.K.2
King, J.3
Swift, A.4
Braun, P.A.5
Park, M.K.6
Ferguson, L.M.7
Nahm, M.H.8
Nabors, G.S.9
-
16
-
-
0030934988
-
Intranasal immunization of mice with PspA (pneumococcal surface protein A) can prevent intranasal carriage, pulmonary infection, and sepsis with Streptococcus pneumoniae
-
Wu, H. Y., M. H. Nahm, Y. Guo, M. W. Russell, and D. E. Briles. 1997. Intranasal immunization of mice with PspA (pneumococcal surface protein A) can prevent intranasal carriage, pulmonary infection, and sepsis with Streptococcus pneumoniae. J. Infect. Dis. 175: 839-846.
-
(1997)
J. Infect. Dis.
, vol.175
, pp. 839-846
-
-
Wu, H.Y.1
Nahm, M.H.2
Guo, Y.3
Russell, M.W.4
Briles, D.E.5
-
17
-
-
0032532645
-
A nontoxic adjuvant for mucosal immunity to pneumococcal surface protein A
-
Yamamoto, M., D. E. Briles, S. Yamamoto, M. Ohmura, H. Kiyono, and J. R. McGhee. 1998. A nontoxic adjuvant for mucosal immunity to pneumococcal surface protein A. J. Immunol. 161: 4115-4121.
-
(1998)
J. Immunol.
, vol.161
, pp. 4115-4121
-
-
Yamamoto, M.1
Briles, D.E.2
Yamamoto, S.3
Ohmura, M.4
Kiyono, H.5
McGhee, J.R.6
-
18
-
-
0031867253
-
Differential kinetics and distribution of antibodies in serum and nasal and vaginal secretions after nasal and oral vaccination of humans
-
Rudin, A., E. L. Johansson, C. Bergquist, and J. Holmgren. 1998. Differential kinetics and distribution of antibodies in serum and nasal and vaginal secretions after nasal and oral vaccination of humans. Infect. Immun. 66: 3390-3396.
-
(1998)
Infect. Immun.
, vol.66
, pp. 3390-3396
-
-
Rudin, A.1
Johansson, E.L.2
Bergquist, C.3
Holmgren, J.4
-
19
-
-
0033023394
-
Antibody responses in the lower respiratory tract and male urogenital tract in humans after nasal and oral vaccination with cholera toxin B subunit
-
Rudin, A., G. C. Riise, and J. Holmgren. 1999. Antibody responses in the lower respiratory tract and male urogenital tract in humans after nasal and oral vaccination with cholera toxin B subunit. Infect. Immun. 67: 2884-2890.
-
(1999)
Infect. Immun.
, vol.67
, pp. 2884-2890
-
-
Rudin, A.1
Riise, G.C.2
Holmgren, J.3
-
20
-
-
17644371966
-
Mucosal immunity and vaccines
-
Holmgren, J., and C. Czerkinsky. 2005. Mucosal immunity and vaccines. Nat. Med. 11(4 Suppl): S45-S53.
-
(2005)
Nat. Med.
, vol.11
, Issue.4 SUPPL.
-
-
Holmgren, J.1
Czerkinsky, C.2
-
21
-
-
36549087144
-
A novel M cell-specific carbohydrate-targeted mucosal vaccine effectively induces antigen- specific immune responses
-
Nochi, T., Y. Yuki, A. Matsumura, M. Mejima, K. Terahara, D. Y. Kim, S. Fukuyama, K. Iwatsuki-Horimoto, Y. Kawaoka, T. Kohda, et al. 2007. A novel M cell-specific carbohydrate-targeted mucosal vaccine effectively induces antigen- specific immune responses. J. Exp. Med. 204: 2789-2796.
-
(2007)
J. Exp. Med.
, vol.204
, pp. 2789-2796
-
-
Nochi, T.1
Yuki, Y.2
Matsumura, A.3
Mejima, M.4
Terahara, K.5
Kim, D.Y.6
Fukuyama, S.7
Iwatsuki-Horimoto, K.8
Kawaoka, Y.9
Kohda, T.10
-
22
-
-
0033984377
-
Intranasal immunization of mice with a mixture of the pneumococcal proteins PsaA and PspA is highly protective against nasopharyngeal carriage of Streptococcus pneumoniae
-
Briles, D. E., E. Ades, J. C. Paton, J. S. Sampson, G. M. Carlone, R. C. Huebner, A. Virolainen, E. Swiatlo, and S. K. Hollingshead. 2000. Intranasal immunization of mice with a mixture of the pneumococcal proteins PsaA and PspA is highly protective against nasopharyngeal carriage of Streptococcus pneumoniae. Infect. Immun. 68: 796-800.
-
(2000)
Infect. Immun.
, vol.68
, pp. 796-800
-
-
Briles, D.E.1
Ades, E.2
Paton, J.C.3
Sampson, J.S.4
Carlone, G.M.5
Huebner, R.C.6
Virolainen, A.7
Swiatlo, E.8
Hollingshead, S.K.9
-
23
-
-
0033104726
-
Targeted deletion of the IgA constant region in mice leads to IgA deficiency with alterations in expression of other Ig isotypes
-
Harriman, G. R., M. Bogue, P. Rogers, M. Finegold, S. Pacheco, A. Bradley, Y. Zhang, and I. N. Mbawuike. 1999. Targeted deletion of the IgA constant region in mice leads to IgA deficiency with alterations in expression of other Ig isotypes. J. Immunol. 162: 2521-2529.
-
(1999)
J. Immunol.
, vol.162
, pp. 2521-2529
-
-
Harriman, G.R.1
Bogue, M.2
Rogers, P.3
Finegold, M.4
Pacheco, S.5
Bradley, A.6
Zhang, Y.7
Mbawuike, I.N.8
-
24
-
-
0030030669
-
IgA class switch in I alpha exon-deficient mice. Role of germline transcription in class switch recombination
-
Harriman, G. R., A. Bradley, S. Das, P. Rogers-Fani, and A. C. Davis. 1996. IgA class switch in I alpha exon-deficient mice. Role of germline transcription in class switch recombination. J. Clin. Invest. 97: 477-485.
-
(1996)
J. Clin. Invest.
, vol.97
, pp. 477-485
-
-
Harriman, G.R.1
Bradley, A.2
Das, S.3
Rogers-Fani, P.4
Davis, A.C.5
-
25
-
-
0028603597
-
Localization of protection-eliciting epitopes on PspA of Streptococcus pneumoniae between amino acid residues 192 and 260
-
McDaniel, L. S., B. A. Ralph, D. O. McDaniel, and D. E. Briles. 1994. Localization of protection-eliciting epitopes on PspA of Streptococcus pneumoniae between amino acid residues 192 and 260. Microb. Pathog. 17: 323-337.
-
(1994)
Microb. Pathog.
, vol.17
, pp. 323-337
-
-
McDaniel, L.S.1
Ralph, B.A.2
McDaniel, D.O.3
Briles, D.E.4
-
26
-
-
0026501145
-
Structural properties and evolutionary relationships of PspA, a surface protein of Streptococcus pneumoniae, as revealed by sequence analysis
-
Yother, J., and D. E. Briles. 1992. Structural properties and evolutionary relationships of PspA, a surface protein of Streptococcus pneumoniae, as revealed by sequence analysis. J. Bacteriol. 174: 601-609.
-
(1992)
J. Bacteriol.
, vol.174
, pp. 601-609
-
-
Yother, J.1
Briles, D.E.2
-
27
-
-
49749093403
-
A combination of Flt3 ligand cDNA and CpG ODN as nasal adjuvant elicits NALT dendritic cells for prolonged mucosal immunity
-
Fukuiwa, T., S. Sekine, R. Kobayashi, H. Suzuki, K. Kataoka, R. S. Gilbert, Y. Kurono, P. N. Boyaka, A. M. Krieg, J. R. McGhee, and K. Fujihashi. 2008. A combination of Flt3 ligand cDNA and CpG ODN as nasal adjuvant elicits NALT dendritic cells for prolonged mucosal immunity. Vaccine 26: 4849-4859.
-
(2008)
Vaccine
, vol.26
, pp. 4849-4859
-
-
Fukuiwa, T.1
Sekine, S.2
Kobayashi, R.3
Suzuki, H.4
Kataoka, K.5
Gilbert, R.S.6
Kurono, Y.7
Boyaka, P.N.8
Krieg, A.M.9
McGhee, J.R.10
Fujihashi, K.11
-
29
-
-
0035853160
-
Peyer's patches are required for oral tolerance to proteins
-
Fujihashi, K., T. Dohi, P. D. Rennert, M. Yamamoto, T. Koga, H. Kiyono, and J. R. McGhee. 2001. Peyer's patches are required for oral tolerance to proteins. Proc. Natl. Acad. Sci. USA 98: 3310-3315.
-
(2001)
Proc. Natl. Acad. Sci. USA
, vol.98
, pp. 3310-3315
-
-
Fujihashi, K.1
Dohi, T.2
Rennert, P.D.3
Yamamoto, M.4
Koga, T.5
Kiyono, H.6
McGhee, J.R.7
-
30
-
-
33747809289
-
A second generation of double mutant cholera toxin adjuvants: Enhanced immunity without intracellular trafficking
-
Hagiwara, Y., Y. I. Kawamura, K. Kataoka, B. Rahima, R. J. Jackson, K. Komase, T. Dohi, P. N. Boyaka, Y. Takeda, H. Kiyono, et al. 2006. A second generation of double mutant cholera toxin adjuvants: enhanced immunity without intracellular trafficking. J. Immunol. 177: 3045-3054. (Pubitemid 44277821)
-
(2006)
Journal of Immunology
, vol.177
, Issue.5
, pp. 3045-3054
-
-
Hagiwara, Y.1
Kawamura, Y.I.2
Kataoka, K.3
Ranima, B.4
Jackson, R.J.5
Komase, K.6
Dohi, T.7
Boyaka, P.N.8
Takeda, Y.9
Kiyono, H.10
McGhee, J.R.11
Fujihashi, K.12
-
31
-
-
0037442215
-
+ T cells in nasopharyngeal- associated lymphoreticular tissue
-
+ T cells in nasopharyngeal- associated lymphoreticular tissue. J. Immunol. 170: 1754-1762.
-
(2003)
J. Immunol.
, vol.170
, pp. 1754-1762
-
-
Hagiwara, Y.1
McGhee, J.R.2
Fujihashi, K.3
Kobayashi, R.4
Yoshino, N.5
Kataoka, K.6
Etani, Y.7
Kweon, M.N.8
Tamura, S.9
Kurata, T.10
-
32
-
-
49749137544
-
A novel adenovirus expressing Flt3 ligand enhances mucosal immunity by inducing mature nasopharyngeal-associated lymphoreticular tissue dendritic cell migration
-
Sekine, S., K. Kataoka, Y. Fukuyama, Y. Adachi, J. Davydova, M. Yamamoto, R. Kobayashi, K. Fujihashi, H. Suzuki, D. T. Curiel, et al. 2008. A novel adenovirus expressing Flt3 ligand enhances mucosal immunity by inducing mature nasopharyngeal-associated lymphoreticular tissue dendritic cell migration. J. Immunol. 180: 8126-8134.
-
(2008)
J. Immunol.
, vol.180
, pp. 8126-8134
-
-
Sekine, S.1
Kataoka, K.2
Fukuyama, Y.3
Adachi, Y.4
Davydova, J.5
Yamamoto, M.6
Kobayashi, R.7
Fujihashi, K.8
Suzuki, H.9
Curiel, D.T.10
-
33
-
-
0026542944
-
Strong association between capsular type and virulence for mice among human isolates of Streptococcus pneumoniae
-
Briles, D. E., M. J. Crain, B. M. Gray, C. Forman, and J. Yother. 1992. Strong association between capsular type and virulence for mice among human isolates of Streptococcus pneumoniae. Infect. Immun. 60: 111-116.
-
(1992)
Infect. Immun.
, vol.60
, pp. 111-116
-
-
Briles, D.E.1
Crain, M.J.2
Gray, B.M.3
Forman, C.4
Yother, J.5
-
34
-
-
53049107872
-
Interleukin-17A mediates acquired immunity to pneumococcal colonization
-
Lu, Y. J., J. Gross, D. Bogaert, A. Finn, L. Bagrade, Q. Zhang, J. K. Kolls, A. Srivastava, A. Lundgren, S. Forte, et al. 2008. Interleukin-17A mediates acquired immunity to pneumococcal colonization. PLoS Pathog. 4: e1000159.
-
(2008)
PLoS Pathog.
, vol.4
-
-
Lu, Y.J.1
Gross, J.2
Bogaert, D.3
Finn, A.4
Bagrade, L.5
Zhang, Q.6
Kolls, J.K.7
Srivastava, A.8
Lundgren, A.9
Forte, S.10
-
35
-
-
68449085481
-
Cellular effectors mediating Th17-dependent clearance of pneumococcal colonization in mice
-
Zhang, Z., T. B. Clarke, and J. N. Weiser. 2009. Cellular effectors mediating Th17-dependent clearance of pneumococcal colonization in mice. J. Clin. Invest. 119: 1899-1909.
-
(2009)
J. Clin. Invest.
, vol.119
, pp. 1899-1909
-
-
Zhang, Z.1
Clarke, T.B.2
Weiser, J.N.3
-
36
-
-
73349104954
-
Intranasal immunization promotes th17 immune responses
-
Zygmunt, B. M., F. Rharbaoui, L. Groebe, and C. A. Guzman. 2009. Intranasal immunization promotes th17 immune responses. J. Immunol. 183: 6933-6938.
-
(2009)
J. Immunol.
, vol.183
, pp. 6933-6938
-
-
Zygmunt, B.M.1
Rharbaoui, F.2
Groebe, L.3
Guzman, C.A.4
-
37
-
-
0032720303
-
Killing of Streptococcus pneumoniae by capsular polysaccharide- specific polymeric IgA, complement, and phagocytes
-
Janoff, E. N., C. Fasching, J. M. Orenstein, J. B. Rubins, N. L. Opstad, and A. P. Dalmasso. 1999. Killing of Streptococcus pneumoniae by capsular polysaccharide- specific polymeric IgA, complement, and phagocytes. J. Clin. Invest. 104: 1139-1147.
-
(1999)
J. Clin. Invest.
, vol.104
, pp. 1139-1147
-
-
Janoff, E.N.1
Fasching, C.2
Orenstein, J.M.3
Rubins, J.B.4
Opstad, N.L.5
Dalmasso, A.P.6
-
38
-
-
66849111904
-
Characterization of protective mucosal and systemic immune responses elicited by pneumococcal surface protein PspA and PspC nasal vaccines against a respiratory pneumococcal challenge in mice
-
Ferreira, D. M., M. Darrieux, D. A. Silva, L. C. Leite, J. M. Ferreira, Jr., P. L. Ho, E. N. Miyaji, and M. L. Oliveira. 2009. Characterization of protective mucosal and systemic immune responses elicited by pneumococcal surface protein PspA and PspC nasal vaccines against a respiratory pneumococcal challenge in mice. Clin. Vaccine Immunol. 16: 636-645.
-
(2009)
Clin. Vaccine Immunol.
, vol.16
, pp. 636-645
-
-
Ferreira, D.M.1
Darrieux, M.2
Silva, D.A.3
Leite, L.C.4
Ferreira Jr., J.M.5
Ho, P.L.6
Miyaji, E.N.7
Oliveira, M.L.8
-
39
-
-
58749105673
-
MyD88 signaling is not essential for induction of antigen-specific B cell responses but is indispensable for protection against Streptococcus pneumoniae infection following oral vaccination with attenuated Salmonella expressing PspA antigen
-
Park, S. M., H. J. Ko, D. H. Shim, J. Y. Yang, Y. H. Park, R. Curtiss, 3rd, and M. N. Kweon. 2008. MyD88 signaling is not essential for induction of antigen-specific B cell responses but is indispensable for protection against Streptococcus pneumoniae infection following oral vaccination with attenuated Salmonella expressing PspA antigen. J. Immunol. 181: 6447-6455.
-
(2008)
J. Immunol.
, vol.181
, pp. 6447-6455
-
-
Park, S.M.1
Ko, H.J.2
Shim, D.H.3
Yang, J.Y.4
Park, Y.H.5
Curtiss III, R.6
Kweon, M.N.7
-
40
-
-
4644242435
-
An important role for polymeric Ig receptor-mediated transport of IgA in protection against Streptococcus pneumoniae nasopharyngeal carriage
-
Sun, K., F. E. Johansen, L. Eckmann, and D. W. Metzger. 2004. An important role for polymeric Ig receptor-mediated transport of IgA in protection against Streptococcus pneumoniae nasopharyngeal carriage. J. Immunol. 173: 4576-4581.
-
(2004)
J. Immunol.
, vol.173
, pp. 4576-4581
-
-
Sun, K.1
Johansen, F.E.2
Eckmann, L.3
Metzger, D.W.4
-
41
-
-
42049088120
-
Optimized immune response elicited by a DNA vaccine expressing pneumococcal surface protein a is characterized by a balanced immunoglobulin G1 (IgG1)/IgG2a ratio and proinflammatory cytokine production
-
Ferreira, D. M., M. Darrieux, M. L. Oliveira, L. C. Leite, and E. N. Miyaji. 2008. Optimized immune response elicited by a DNA vaccine expressing pneumococcal surface protein a is characterized by a balanced immunoglobulin G1 (IgG1)/IgG2a ratio and proinflammatory cytokine production. Clin. Vaccine Immunol. 15: 499-505.
-
(2008)
Clin. Vaccine Immunol.
, vol.15
, pp. 499-505
-
-
Ferreira, D.M.1
Darrieux, M.2
Oliveira, M.L.3
Leite, L.C.4
Miyaji, E.N.5
-
42
-
-
33846141477
-
Mucosal delivery of a pneumococcal vaccine using Lactococcus lactis affords protection against respiratory infection
-
Hanniffy, S. B., A. T. Carter, E. Hitchin, and J. M. Wells. 2007. Mucosal delivery of a pneumococcal vaccine using Lactococcus lactis affords protection against respiratory infection. J. Infect. Dis. 195: 185-193.
-
(2007)
J. Infect. Dis.
, vol.195
, pp. 185-193
-
-
Hanniffy, S.B.1
Carter, A.T.2
Hitchin, E.3
Wells, J.M.4
-
43
-
-
67349273778
-
Intranasal immunization with a mixture of PspA and a Toll-like receptor agonist induces specific antibodies and enhances bacterial clearance in the airways of mice
-
Oma, K., J. Zhao, H. Ezoe, Y. Akeda, S. Koyama, K. J. Ishii, K. Kataoka, and K. Oishi. 2009. Intranasal immunization with a mixture of PspA and a Toll-like receptor agonist induces specific antibodies and enhances bacterial clearance in the airways of mice. Vaccine 27: 3181-3188.
-
(2009)
Vaccine
, vol.27
, pp. 3181-3188
-
-
Oma, K.1
Zhao, J.2
Ezoe, H.3
Akeda, Y.4
Koyama, S.5
Ishii, K.J.6
Kataoka, K.7
Oishi, K.8
-
44
-
-
0033037090
-
Treatment of community-acquired pneumonia - IDSA guidelines
-
Infectious Diseases Society of America
-
Bernstein, J. M.; Infectious Diseases Society of America. 1999. Treatment of community-acquired pneumonia - IDSA guidelines. Chest 115(3 Suppl): 9S-13S.
-
(1999)
Chest
, vol.115
, Issue.3 SUPPL.
-
-
Bernstein, J.M.1
-
46
-
-
0033954496
-
Immunity to influenza in the elderly
-
Webster, R. G. 2000. Immunity to influenza in the elderly. Vaccine 18: 1686-1689.
-
(2000)
Vaccine
, vol.18
, pp. 1686-1689
-
-
Webster, R.G.1
-
47
-
-
0030983708
-
Mortality by cause for eight regions of the world: Global Burden of Disease Study
-
Murray, C. J., and A. D. Lopez. 1997. Mortality by cause for eight regions of the world: Global Burden of Disease Study. Lancet 349: 1269-1276.
-
(1997)
Lancet
, vol.349
, pp. 1269-1276
-
-
Murray, C.J.1
Lopez, A.D.2
-
48
-
-
0034326637
-
Evidence for early aging in the mucosal immune system
-
Koga, T., J. R. McGhee, H. Kato, R. Kato, H. Kiyono, and K. Fujihashi. 2000. Evidence for early aging in the mucosal immune system. J. Immunol. 165: 5352-5359.
-
(2000)
J. Immunol.
, vol.165
, pp. 5352-5359
-
-
Koga, T.1
McGhee, J.R.2
Kato, H.3
Kato, R.4
Kiyono, H.5
Fujihashi, K.6
|